2021;103 (11):680-687
Atrial fibrillation is a source of significant morbidity and Nosebleed (Epistaxis) (Affirmation of Value, April 2020) The “Clinical Practice Guideline: Nosebleed (Epistaxis)” was developed by the American Academy of Otolaryngology-Head and Neck Surgery Ischemic stroke is the result of a sudden blockage of blood flow to the central nervous system due to thrombotic or embolic phenomena, and it is a major cause of morbidity and mortality worldwide The authors conclude that maintaining the same warfarin dosage in asymptomatic patients with a slightly elevated INR of 3
81 to 4
Identification of bleeding and bruising and appropriate intervention can decrease the associated morbidity and mortality
1 – 6 The expectoration of blood-tinged sputum and mild to moderate hemoptysis should be The most common causes of elevated transaminase levels are nonalcoholic fatty liver disease and alcoholic liver disease
A patient history and physical examination with a complete blood count, C-reactive protein, anti-tissue Chronic anticoagulation is recommended for patients who have atrial fibrillation unless they are at low risk of stroke (CHADS 2 <2) or have specific contraindications (strong recommendation, high The prevalence of hypertension in the inpatient setting is between 51% and 72%, based on 24-hour blood pressure monitoring
39 Patients with recurrent or unprovoked venous Patients with ACS should receive coronary angiography with percutaneous or surgical revascularization
0-3